Your browser doesn't support javascript.
loading
A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
Tasaki, Masayuki; Tateno, Hiroaki; Sato, Takashi; Tomioka, Azusa; Kaji, Hiroyuki; Narimatsu, Hisashi; Saito, Kazuhide; Nakagawa, Yuki; Aoki, Toshinari; Kamimura, Masami; Ushiki, Takashi; Okada, Manabu; Miwa, Yuko; Hotta, Kiyohiko; Yoshida, Yutaka; Takahashi, Kota; Tomita, Yoshihiko.
Afiliação
  • Tasaki M; Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Tateno H; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
  • Sato T; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
  • Tomioka A; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
  • Kaji H; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
  • Narimatsu H; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
  • Saito K; Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Nakagawa Y; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Aoki T; Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Kamimura M; Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Ushiki T; Department of Transfusion Medicine, Cell Therapy and Regenerative Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Okada M; Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
  • Miwa Y; Department of Kidney Disease and Transplant Immunology, Aichi Medical University School of Medicine, Nagoya, Japan.
  • Hotta K; Department of Urology, Hokkaido University Hospital, Sapporo, Japan.
  • Yoshida Y; Department of Structural Pathology, Kidney Research Center, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Takahashi K; Takahashi Memorial Medical Institute, Tokyo, Japan.
  • Tomita Y; Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Transpl Int ; 35: 10248, 2022.
Article em En | MEDLINE | ID: mdl-35401036
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article